Skip to main content
Novartis AG logo

Novartis AG — Investor Relations & Filings

Ticker · NOVN ISIN · CH0038459415 LEI · 5493007HIVTX6SY6XD66 SW Manufacturing
Open in API
Filings indexed 1,070 across all filing types
Latest filing 2015-07-20 Regulatory Filings
Country CH Switzerland
Listing SW NOVN

About Novartis AG

https://www.novartis.com/

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter from Novartis AG to the SEC regarding comments on their Form 20-F filing for the fiscal year ended December 31, 2014. It discusses responses to SEC staff comments and planned changes for the next Form 20-F filing for 2015. The document is a correspondence addressing regulatory comments rather than the actual annual report or financial statements. It does not contain financial data or the report itself but is a regulatory communication related to the filing. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3626 characters, which is relatively short and consistent with a letter or comment response rather than a full report.
2015-07-20 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-17 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-15 English
Annual Report 2015
Annual Report Classification · 100% confidence The document is a detailed letter from Novartis AG to the SEC responding to comments on their Form 20-F for the fiscal year ended December 31, 2014. It includes detailed financial data, discussion of continuing and discontinued operations, and reconciliations of IFRS and non-IFRS measures. The presence of a fiscal year-end date, detailed financial results, and discussion of operating and financial review and prospects indicates this is part of an annual report filing. The Form 20-F is the annual report filed by foreign private issuers with the SEC, equivalent to a 10-K. The document is not a brief announcement or a certification letter but contains substantive financial data and management discussion. Therefore, the correct classification is Annual Report (10-K equivalent).
2015-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-18 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-16 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.